Impact of the HER2 Expression on Survival and Fluorouracil-Based Adjuvant Chemotherapeutic Benefits in Stage II/III Gastric Cancer: A Multicenter Observational Study
Xianchun Gao(National Clinical Research Center for Digestive Diseases), MAGIS Study Group, Lei Shang(State Council of the People's Republic of China), Wenjiao Li(Central South University), Renlong Li(State Council of the People's Republic of China), Kaichun Wu(State Council of the People's Republic of China), Han Liang(The University of Texas MD Anderson Cancer Center), Yingtai Chen(Shanghai Jiao Tong University), Xiaoliang Gao(National Clinical Research Center for Digestive Diseases), Penghui Niu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lulu Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongwei Li(National Clinical Research Center for Digestive Diseases), Kun Liu(Air Liquide (United Kingdom)), Ling Chen(Nanjing Drum Tower Hospital), Nannan Zhang(Lanzhou University), Shibo Wang(National Clinical Research Center for Digestive Diseases), Yongzhan Nie(Xijing Hospital), Wanqing Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zengshan Li(Xijing Hospital), Gang Ji(Centre National de la Recherche Scientifique), Weili Han(National Clinical Research Center for Digestive Diseases), Haohao Zhang(State Council of the People's Republic of China), Qingchuan Zhao(City University of Hong Kong), Jingyu Deng(Tianjin Medical University Cancer Institute and Hospital), Yuanyuan Lu(National Clinical Research Center for Digestive Diseases), Junya Yan(National Clinical Research Center for Digestive Diseases), Yan Pan(National Clinical Research Center for Digestive Diseases)
Cited by 0
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641